{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:27:06Z","timestamp":1773394026954,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12072-016-9737-2","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T06:06:00Z","timestamp":1463724360000},"page":"779-788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure"],"prefix":"10.1007","volume":"10","author":[{"given":"Fabien","family":"Zoulim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Bia\u0142kowska-Warzecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mircea Mihai","family":"Diculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian Eugen","family":"Goldis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Heyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Marcellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumaya","family":"Bendahmane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Klauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Wasiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L. A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"9737_CR1","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167\u2013185","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"9737_CR2","doi-asserted-by":"crossref","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661\u2013662","DOI":"10.1002\/hep.23190"},{"key":"9737_CR3","doi-asserted-by":"crossref","unstructured":"Liaw YF, Kao JH, Piratvisuth T, Chan HLY, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 2012;6:531\u2013561","DOI":"10.1007\/s12072-012-9365-4"},{"key":"9737_CR4","doi-asserted-by":"crossref","unstructured":"Zoulim F, Locarnini S. Management of treatment failure in chronic hepatitis B. J Hepatol 2012;56(Suppl 1):S112\u2013S122","DOI":"10.1016\/S0168-8278(12)60012-9"},{"key":"9737_CR5","doi-asserted-by":"crossref","unstructured":"Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009;137:1593\u20131608","DOI":"10.1053\/j.gastro.2009.08.063"},{"key":"9737_CR6","doi-asserted-by":"crossref","unstructured":"Gaia S, Barbon V, Smedile A, Olivero A, Carenzi S, Lagget M, et al. Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine. J Hepatol 2008;48:540\u2013547","DOI":"10.1016\/j.jhep.2007.12.018"},{"key":"9737_CR7","doi-asserted-by":"crossref","unstructured":"Pellicelli AM, Barbaro G, Francavilla R, Romano M, Barbarini G, Mazzoni E, et al. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. Clin Ther 2008;30:317\u2013323","DOI":"10.1016\/j.clinthera.2008.02.012"},{"key":"9737_CR8","doi-asserted-by":"crossref","unstructured":"Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, et al. Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy. J Med Virol 2008;80:1160\u20131170","DOI":"10.1002\/jmv.21206"},{"key":"9737_CR9","doi-asserted-by":"crossref","unstructured":"Kwon HC, Cheong JY, Cho SW, Choi JM, Hong SP, Kim SO, et al. Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy. J Gastroenterol Hepatol 2009;24:49\u201354","DOI":"10.1111\/j.1440-1746.2008.05570.x"},{"key":"9737_CR10","doi-asserted-by":"crossref","unstructured":"Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-na\u00efve patients is rare through 5 years of therapy. Hepatology 2009;49:1503\u20131514","DOI":"10.1002\/hep.22841"},{"key":"9737_CR11","doi-asserted-by":"crossref","unstructured":"Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013;381:468\u2013475","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"9737_CR12","doi-asserted-by":"crossref","unstructured":"Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, et al. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-na\u00efve patients with chronic hepatitis B. Gastroenterology 2012;143(619\u2013628):e1","DOI":"10.1053\/j.gastro.2012.05.037"},{"key":"9737_CR13","doi-asserted-by":"crossref","unstructured":"Petersen J, Ratziu V, Buti M, Janssen HL, Brown A, Lampertico P, et al. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol 2012;56:520\u2013526","DOI":"10.1016\/j.jhep.2011.09.018"},{"key":"9737_CR14","unstructured":"Park JY, Kim CW, Bae SH, Hoon S. Entecavir plus tenofovir combination therapy in patients with multi-drug resistant chronic hepatitis B: the 48-week results of a multicenter, prospective study. Hepatology 2014;60:1096A (abstract 1865)"},{"key":"9737_CR15","doi-asserted-by":"crossref","unstructured":"Lee YB, Lee JH, Lee DH, Cho H, Ahn H, Choi WM, et al. Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains. Antimicrob Agents Chemother 2014;58:6710\u20136716","DOI":"10.1128\/AAC.03845-14"},{"key":"9737_CR16","doi-asserted-by":"publisher","unstructured":"Lim YS, Byun KS, Yoo BC, Kwon SY, Kim YJ, An J, et al. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial. Gut 2015. doi: 10.1136\/gutjnl-2014-308353","DOI":"10.1136\/gutjnl-2014-308353"},{"key":"9737_CR17","doi-asserted-by":"crossref","unstructured":"Lutgehetmann M, Schollmeyer J, Volz T, Lohse A, Buggisch P, Sterneck M, et al. Rescue therapy with combination of entecavir and tenofovir in patients with chronic HBV, advanced fibrosis and multiple previous treatment failures is safe and highly efficient. J Hepatol 2009;50(suppl):S335 (poster 922)","DOI":"10.1016\/S0168-8278(09)60924-7"},{"key":"9737_CR18","doi-asserted-by":"crossref","unstructured":"Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, et al. Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. J Hepatol 2009;51:11\u201320","DOI":"10.1016\/j.jhep.2008.12.019"},{"key":"9737_CR19","doi-asserted-by":"crossref","unstructured":"van B\u00f6mmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues. Hepatology 2010;51:73\u201380","DOI":"10.1002\/hep.23246"},{"key":"9737_CR20","doi-asserted-by":"crossref","unstructured":"Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, et al. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut 2011;60:247\u2013254","DOI":"10.1136\/gut.2010.223206"},{"key":"9737_CR21","doi-asserted-by":"crossref","unstructured":"Berg T, Marcellin P, Zoulim F, Moller B, Trinh H, Chan S, et al. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology 2010;139:1207\u20131217","DOI":"10.1053\/j.gastro.2010.06.053"},{"key":"9737_CR22","doi-asserted-by":"crossref","unstructured":"Berg T, Zoulim F, Moeller B, Trinh H, Marcellin P, Chan S, et al. Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. J Hepatol 2014;60:715\u2013722","DOI":"10.1016\/j.jhep.2013.11.024"},{"key":"9737_CR23","doi-asserted-by":"crossref","unstructured":"Kim YJ, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, et al. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures. World J Gastroenterol 2012;18:6996\u20137002","DOI":"10.3748\/wjg.v18.i47.6996"},{"key":"9737_CR24","doi-asserted-by":"publisher","unstructured":"Lim YS, Yoo BC, Byun KS, Kwon SY, Kim YJ, An J, et al. Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial. Gut 2015. doi: 10.1136\/gutjnl-2014-308435","DOI":"10.1136\/gutjnl-2014-308435"},{"key":"9737_CR25","doi-asserted-by":"crossref","unstructured":"Keskin O, Ormeci AC, Baran B, Kaba\u00e7am G, T\u00fcz\u00fcn A, Karatayli E, et al. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B. Antivir Ther 2014;19:543\u2013550","DOI":"10.3851\/IMP2732"},{"key":"9737_CR26","doi-asserted-by":"crossref","unstructured":"Lavocat F, D\u00e9ny P, Pichoud C, Al Hawajri N, Kitrinos K, Borroto-Esoda K, et al. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir\/emtricitabine combination or tenofovir monotherapy. J Hepatol 2013;59:684\u2013695","DOI":"10.1016\/j.jhep.2013.05.038"},{"key":"9737_CR27","doi-asserted-by":"crossref","unstructured":"van B\u00f6mmel F, Trojan J, Deterding K, Wedemeyer H, Wasmuth HE, H\u00fcppe D, et al. Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy. Antivir Ther 2012;17:1049\u20131058","DOI":"10.3851\/IMP2307"},{"key":"9737_CR28","unstructured":"Lee S, Park JY, Park H, Kim MY, Ahn SH, Kim P, et al. Tenofovir mono-rescue therapy vs. tenofovir plus entecavir combination-rescue therapy in chronic hepatitis B with lamivudine and entecavir resistance: a Korean multi-center study. Hepatology 2014;60:1105A (abstract 1880)"},{"key":"9737_CR29","doi-asserted-by":"crossref","unstructured":"Zoutendijk R, Reijnders JG, Brown A, Zoulim F, Mutimer D, Deterding K, et al. Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of na\u00efve patients with a partial virological response. Hepatology 2011;54:443\u2013451","DOI":"10.1002\/hep.24406"},{"key":"9737_CR30","doi-asserted-by":"crossref","unstructured":"Luo J, Li X, Wu Y, Lin G, Pang Y, Zhang X, et al. Efficacy of entecavir treatment for up to 5 years in nucleos(t)ide-na\u00efve chronic hepatitis B patients in real life. Int J Med Sci 2013;10:427\u2013433","DOI":"10.7150\/ijms.5472"},{"key":"9737_CR31","doi-asserted-by":"crossref","unstructured":"Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 2013;58:98\u2013107","DOI":"10.1002\/hep.26180"},{"key":"9737_CR32","doi-asserted-by":"crossref","unstructured":"Tien C, Xu JJ, Chan LS, Chang M, Lim C, Lee S, et al. Long-term treatment with tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling. Dig Dis Sci 2015;60:566\u2013572","DOI":"10.1007\/s10620-014-3363-4"},{"key":"9737_CR33","doi-asserted-by":"crossref","unstructured":"Gara N, Zhao X, Collins MT, Chong WH, Kleiner DE, Jake Liang T, et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther 2012;35:1317\u20131325","DOI":"10.1111\/j.1365-2036.2012.05093.x"},{"key":"9737_CR34","doi-asserted-by":"crossref","unstructured":"Gracey DM, Snelling P, McKenzie P, Strasser SI. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection. Antivir Ther 2013;18:945\u2013948","DOI":"10.3851\/IMP2649"},{"key":"9737_CR35","doi-asserted-by":"crossref","unstructured":"Vigano M, Lampertico P, Mangia G, Soffredini R, Facchetti F, Invernizzi F, et al. Incidence and clinical consequences of reduced tubular phosphate reabsorption in na\u00efve chronic hepatitis B patients either untreated or treated with tenofovir for 2\u00a0years in a field practice study. Hepatology 2013;58 (suppl):678A (abstract 978)","DOI":"10.1016\/S0168-8278(13)60779-5"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-016-9737-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-016-9737-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T23:30:23Z","timestamp":1567899023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-016-9737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9737"],"URL":"https:\/\/doi.org\/10.1007\/s12072-016-9737-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}